A study that evaluated the safety, acceptability and ease of use of the microbicide candidate VivaGel® in sexually active, HIV-negative women ages 18 to 24.
See
May 25, 2010
Jul 9, 2007
See Also
MTN-004
Media Contacts
Lisa
Rossi
Office: +1 412 641-8940
Mobile: +1 412 916-3315
rossil@upmc.edu
Clare
Collins
Office: +1 412 641-7299
Mobile: +1 412 770-8643
collcx@upmc.edu